RBC Capital Maintains Outperform on Ardent Health, Raises Price Target to $18

Benzinga · 1d ago
RBC Capital analyst Ben Hendrix maintains Ardent Health (NYSE:ARDT) with a Outperform and raises the price target from $13 to $18.